ArticleCancer management and research2021

Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent

Yonghui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.